Singapore-based firm to start human trials for Covid-19 treatment


Team Udayavani, Jun 12, 2020, 11:02 AM IST

Tychan, Singaporean biotechnology firm,  will begin human clinical trials next week for a potential monoclonal antibody treatment for Covid-19

The first phase of the trial will be conducted on healthy volunteers to determine the safety and tolerability of TY027, a monoclonal antibody or immune system protein that specifically targets the virus that causes Covid-19.

TY027 is being explored for its ability to slow down the progression of Covid-19 and speed up recovery, and its potential to provide temporary protection against infection

It is said that if phase one is successful, Tychan will seek approval for the antibody to be administered to a larger population of volunteer patients in subsequent trials.

 

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

2 detained for killing tailor in Rajasthan’s Udaipur

Stinking toilets on trains: Railways deploys senior officials for inspection

Taapsee Pannu on teaming up with SRK in ‘Dunki’: It’s a golden opportunity

Eoin Morgan retires, draws curtains on glorious international career

Udupi: Youth enacts kidnap drama to extort Rs 5 Lakhs; ends up behind bars

Tailor murdered over ‘insult to Islam’, tension in Udaipur

No hike in electricity tariff for consumers for now: Min Sunil Kumar issues clarification


Related Articles More

Russia bans Biden’s wife, daughter from entry

Regrettable that still no agreement on Constitutional basis for holding elections in Libya: India

48 migrants die after trailer abandoned in Texas heat

Cyberattack forces Iran steel company to halt production

Sri Lanka to operate only essential services till July 10 amidst acute fuel shortage

MUST WATCH

Bride breaks down after receiving wax statue of her late father as a gift. Video divides Internet

House Caught Fire at Kumta

Major Road Mishap at Hunasur, 1 killed and 4 injured

Vijayapura And Dotihal Tradition : farmers Celebrating Amavasya

Khadar speaks about developmental activities


Latest Additions

Zubair’s ‘objectionable’ tweet of 2018 led to Twitter storm with ‘hate’ speeches: Delhi Police

2 detained for killing tailor in Rajasthan’s Udaipur

Maha CM Thackeray chairs cabinet meeting, first after taking away rebel ministers’ portfolios

Stinking toilets on trains: Railways deploys senior officials for inspection

Taapsee Pannu on teaming up with SRK in ‘Dunki’: It’s a golden opportunity

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.